Literature DB >> 435052

White clot syndrome. Peripheral vascular complications of heparin therapy.

J B Towne, V M Bernhard, C Hussey, J C Garancis.   

Abstract

Heparin sodium-induced thrombosis is insidious and difficult to diagnose. If untreated, it results in death or major amputation. We have treated seven patients with thromboses resulting from platelet aggregation induced by heparin. Four patients had acute arterial ischemia of the lower extremity, venous gangrene developed in two, and one patient had an occluded autogenous vein femoral popliteal bypass in the immediate postoperative period. The platelet count was noticeably reduced in affected patients. White platelet thrombi were noted in four patients, three of whom had acute arterial occlusion. A white thrombus was the cause of immediate failure of a femoral popliteal graft. Electron microscopic examination of these thrombi demonstrated predominantly fibrin platelet aggregates with an occasional entrapped WBC and a rare RBC. All patients receiving heparin therapy must have platelet counts performed regularly. If thrombocytopenia is detected, platelet aggregation studies are indicated. When abnormal platelet aggregation is noted, heparin therapy should be reversed with protamine sulfate and the patient treated with low-molecular-weight dextran and warfarin sodium.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 435052     DOI: 10.1001/archsurg.1979.01370280026004

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  9 in total

Review 1.  Heparin-induced thrombocytopenia: patient profiles and clinical manifestations.

Authors:  F A Spencer
Journal:  J Thromb Thrombolysis       Date:  2000-11       Impact factor: 2.300

2.  Acute aortic occlusion in a patient with heparin-induced thrombocytopenia treated by thrombectomy.

Authors:  D Collins; M A Moloney; D O'Donnell; D Brophy; S J Sheehan
Journal:  Ir J Med Sci       Date:  2010-07-28       Impact factor: 1.568

3.  Recognition of PF4-VWF complexes by heparin-induced thrombocytopenia antibodies contributes to thrombus propagation.

Authors:  Ian Johnston; Amrita Sarkar; Vincent Hayes; Gavin T Koma; Gowthami M Arepally; Junmei Chen; Dominic W Chung; José A López; Douglas B Cines; Lubica Rauova; Mortimer Poncz
Journal:  Blood       Date:  2020-04-09       Impact factor: 25.476

4.  Fibrinogen mediated activation of platelet aggregation and thromboxane A2 release: pathological implications in vascular disease.

Authors:  D P Mikhailidis; M A Barradas; A Maris; J Y Jeremy; P Dandona
Journal:  J Clin Pathol       Date:  1985-10       Impact factor: 3.411

5.  [Intermittent mechanical massage for the prevention of thromboembolism].

Authors:  G H Ott; N Grünewald
Journal:  Langenbecks Arch Chir       Date:  1986

Review 6.  Heparin pharmacokinetics and pharmacodynamics.

Authors:  R J Kandrotas
Journal:  Clin Pharmacokinet       Date:  1992-05       Impact factor: 6.447

7.  [Heparin-induced thrombocytopenia with unfractionated heparin. A prospective study of inpatient treatment of internal medicine patients].

Authors:  H Heidrich; K Kahl; C Penninger; B Bechstein; M Birkenmaier; S Dressler; C Fahrig; J Helmis; G Herman; U von Knobloch; M Ladleif; K Meier; M Rudolph; B Schlich; M Wanke; B Zwernemann
Journal:  Med Klin (Munich)       Date:  1998-06-15

8.  A huge thrombosed pulmonary artery aneurysm without pulmonary hypertension in a patient with hepatosplenic schistosomiasis.

Authors:  Elsayed S Abo-Salem; Mahmoud M Ramadan
Journal:  Am J Case Rep       Date:  2015-03-08

Review 9.  Stroke Associated with COVID-19 Vaccines.

Authors:  Maryam Kakovan; Samaneh Ghorbani Shirkouhi; Mojtaba Zarei; Sasan Andalib
Journal:  J Stroke Cerebrovasc Dis       Date:  2022-03-04       Impact factor: 2.677

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.